Am J Transplant, Volume 19, Suppl 3 Archives - Page 189 of 214 - ATC Abstracts

2019 American Transplant Congress
Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series
E. A. Gerzina¹, E. D. Witte¹, M. L. Kueht², R. W. Himes³
¹Baylor College of Medicine, Houston, TX, ²Department of Surgery, Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX, ³Pediatrics--Gastroenterology, Baylor College of Medicine, Houston, TX
*Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…
2019 American Transplant Congress
Targeted Antifungal Prophylaxis in Liver Transplant Recipients: Two Year, Retrospective Cohort Analysis
N. Persun¹, J. Doyon², E. Blumberg², S. Prenner², V. Khungar², P. Abt³, C. Sammons¹
¹Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, ³Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: No consensus exists regarding systemic antifungal prophylaxis in liver transplant recipients (LTRs) in terms of optimal duration, choice of agent, or risk factors to…
2019 American Transplant Congress
Infectious Complications in Kidney Transplant Recipients Age 65 and Older
L. E. Liriano-Ward¹, M. Barbachan e Silva², Y. Azzi¹, M. Ajaimy¹, A. Cambell¹, J. Graham¹, J. Rocca¹, C. Pynadath¹, G. Nair¹, O. Andacoglu¹, S. Greenstein¹, P. Ó Broin², E. Akalin¹
¹Transplant, Einstein/Montefiore Medical Center, Bronx, NY, ²School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland
*Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…
2019 American Transplant Congress
Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society of Transplantation
M. So¹, J. Hand², M. Richmond¹, A. Morris³, S. Husain¹
¹University Health Network, Toronto, ON, Canada, ²Ochsner Medical Center, New Orleans, LA, ³Sinai Health System, Toronto, ON, Canada
*Purpose: The perceptions and attitude of transplant clinicians towards antimicrobial stewardship (AMS) is unclear. We conducted a survey to better understand their attitude and perceptions…
2019 American Transplant Congress
Normothermic Machine Perfusion of Human Kidneys without an Oxygen Carrier
D. Detelich, C. Eymard, M. Aburawi, C. Carroll, K. Uygun, H. Yeh, J. F. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: Normothermic machine perfusion (NMP) is a promising strategy for pre-transplant reconditioning and viability assessment of marginal renal grafts. All current clinical kidney NMP protocols…
2019 American Transplant Congress
Predicting Risk of Cytomegalovirus with Viral-Antigen-Specific CD154+ T-cells after Liver or Intestine Transplantation
C. Ashokkumar, K. Soltys, M. Green, G. Mazariegos, G. Bond, K. Jones, A. Rzempoluch, M. Zaccagnini, P. Sethi, B. W. Higgs, R. Sindhi
Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: Cytomegalovirus (CMV)-specific T-cells express IFNγ, measure cell-mediated immunity to CMV and can guide the timing and duration of antiviral therapy. CMV-specific T-cells also co-express…
2019 American Transplant Congress
Urinary Extracellular Vesicles-Related Protein Biomarkers for the Non-Invasive Monitoring of Rejection in Kidney Transplanted Patients
L. Carreras-Planella¹, I. Bancu², D. Cucchiari³, L. Cañas², J. Juega², M. Franquesa¹, M. Perez-Mir², I. Revuelta³, F. Diekman⁴, R. Lauzurica², F. Borràs¹
¹REMAR-IVECAT Group, Institut Germans Trias i Pujol, Badalona, Spain, ²Nephrology- Renal Transplant Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ³Dept. Nefrologia i Trasplantament Renal, Institut Clínicde Nefrologia i Urologia (ICNU), Hospital Clinic, Barcelona, Spain, ⁴Dept. Nefrologia i Trasplantament Renal, Institut Clínicde Nefrologia i Urologia (ICNU), Hospital Clinic, Badalona, Spain
*Purpose: Chronic kidney rejection is currently the main cause of graft losses. Blood and urine analyses to monitor kidney transplanted patients are not specific, and…
2019 American Transplant Congress
Comparison between Urine and Blood NGAL for Early Prediction of Delayed Graft Function in Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Y. Li, Y. Li, L. Yan, H. Wang, X. Wu, J. Tang, L. Wang, Y. Shi
Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Neutrophil gelatinase-assoicated lipocalin (NGAL) appears to be a promising proximal tubular injury biomarker for early prediction of delayed graft function (DGF) in kidney transplant…
2019 American Transplant Congress
Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naïve Hepatocellular Carinoma Patients
K. Nunez, T. Sandow, S. Robertson, P. Thevenot, A. Cohen
Ochsner Health System, New Orleans, LA
*Purpose: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related deaths in the world with recurrence rates at 40%. Locoregional therapy (LRT) is standard…
2019 American Transplant Congress
Unfair Waiting Time Calculation? Impact of Accumulated Wait Time Restart with a Decrease in Status from 1A to 1B or 2 on Mortality of Heart Transplant Candidates
S. Yu, M. Kosztowski, M. Waldram, D. L. Segev, A. B. Massie
Department of Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Between two heart transplant (HT) candidates listed at the same status, the candidate with longer accumulated wait time receives higher waitlist priority; under current…